CN102698185A - 一种治疗高血脂症的藏药及其制备方法 - Google Patents
一种治疗高血脂症的藏药及其制备方法 Download PDFInfo
- Publication number
- CN102698185A CN102698185A CN2012102344118A CN201210234411A CN102698185A CN 102698185 A CN102698185 A CN 102698185A CN 2012102344118 A CN2012102344118 A CN 2012102344118A CN 201210234411 A CN201210234411 A CN 201210234411A CN 102698185 A CN102698185 A CN 102698185A
- Authority
- CN
- China
- Prior art keywords
- tibetan medicine
- fructus
- active component
- corydalisimpatiens
- fisch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 67
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title description 11
- 241000530044 Herpetospermum Species 0.000 claims abstract description 17
- 241000628997 Flos Species 0.000 claims description 17
- 235000012239 silicon dioxide Nutrition 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000007560 sedimentation technique Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 18
- 210000002784 stomach Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 7
- 238000010792 warming Methods 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 5
- 208000026435 phlegm Diseases 0.000 abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 244000294611 Punica granatum Species 0.000 abstract description 2
- 240000000513 Santalum album Species 0.000 abstract description 2
- 235000008632 Santalum album Nutrition 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 241001573260 Amomum krervanh Species 0.000 abstract 1
- 241001346334 Amomum tsao-ko Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 241001495448 Impatiens <genus> Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000015241 bacon Nutrition 0.000 abstract 1
- 238000007791 dehumidification Methods 0.000 abstract 1
- 229930190166 impatien Natural products 0.000 abstract 1
- 230000000149 penetrating effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 26
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 14
- 241000700159 Rattus Species 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 230000009471 action Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 150000002632 lipids Chemical class 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000008802 xuezhikang Substances 0.000 description 5
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000018556 stomach disease Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000059800 Amomum compactum Species 0.000 description 1
- 235000016426 Amomum compactum Nutrition 0.000 description 1
- 241001533085 Aquilaria sinensis Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001317465 Bambusa textilis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000012239 Developmental disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000530047 Herpetospermum pedunculosum Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029164 Nephrotic syndrome Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000000103 Potentilla erecta Species 0.000 description 1
- 235000016551 Potentilla erecta Nutrition 0.000 description 1
- 241000221035 Santalaceae Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000403513 Schizostachyum chinense Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003591 anti-choleraic effect Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 108700022737 rat Fat1 Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000004026 tunica intima Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210234411 CN102698185B (zh) | 2012-07-09 | 2012-07-09 | 一种治疗高血脂症的藏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210234411 CN102698185B (zh) | 2012-07-09 | 2012-07-09 | 一种治疗高血脂症的藏药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102698185A true CN102698185A (zh) | 2012-10-03 |
CN102698185B CN102698185B (zh) | 2013-06-19 |
Family
ID=46891432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210234411 Active CN102698185B (zh) | 2012-07-09 | 2012-07-09 | 一种治疗高血脂症的藏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102698185B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417842A (zh) * | 2013-07-29 | 2013-12-04 | 高丽丽 | 一种治疗和预防心脑血管疾病的中药制剂及制备方法 |
CN105213539A (zh) * | 2014-05-27 | 2016-01-06 | 山东阿如拉药物研究开发有限公司 | 十一味金色丸在制备治疗高脂血症药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1712058A (zh) * | 2005-07-07 | 2005-12-28 | 甘肃奇正藏药有限公司 | 一种治疗头昏目眩和血压不调的藏药制剂及其制备方法 |
CN1879839A (zh) * | 2006-05-15 | 2006-12-20 | 内蒙古蒙药股份有限公司 | 一种治疗高脂血症的蒙药保利尔及其制备方法 |
CN101683446A (zh) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | 一种通脉降脂中药组合物 |
-
2012
- 2012-07-09 CN CN 201210234411 patent/CN102698185B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1712058A (zh) * | 2005-07-07 | 2005-12-28 | 甘肃奇正藏药有限公司 | 一种治疗头昏目眩和血压不调的藏药制剂及其制备方法 |
CN1879839A (zh) * | 2006-05-15 | 2006-12-20 | 内蒙古蒙药股份有限公司 | 一种治疗高脂血症的蒙药保利尔及其制备方法 |
CN101683446A (zh) * | 2008-09-23 | 2010-03-31 | 天津市中宝制药有限公司 | 一种通脉降脂中药组合物 |
Non-Patent Citations (2)
Title |
---|
李岑 等: "复方藏药当佐脂溶性成分GC-MS分析", 《中草药》, vol. 42, no. 12, 31 December 2011 (2011-12-31), pages 2413 - 2417 * |
邓玲 等: "中医药治疗高脂血症的研究进展", 《中国康复理论与实践》, vol. 12, no. 3, 31 March 2006 (2006-03-31), pages 228 - 229 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103417842A (zh) * | 2013-07-29 | 2013-12-04 | 高丽丽 | 一种治疗和预防心脑血管疾病的中药制剂及制备方法 |
CN103417842B (zh) * | 2013-07-29 | 2015-09-02 | 高丽丽 | 一种治疗和预防心脑血管疾病的中药制剂及制备方法 |
CN105213539A (zh) * | 2014-05-27 | 2016-01-06 | 山东阿如拉药物研究开发有限公司 | 十一味金色丸在制备治疗高脂血症药物中的应用 |
CN105213539B (zh) * | 2014-05-27 | 2019-01-25 | 金诃藏药(山东)健康产业有限公司 | 十一味金色丸在制备治疗高脂血症药物中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102698185B (zh) | 2013-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104383132B (zh) | 一种用于治疗胃溃疡的中药制剂及制备方法 | |
CN102772781A (zh) | 一种治疗慢性结肠炎的中药制剂及其制备方法 | |
CN105250821B (zh) | 一种用于治疗溃疡性结肠炎的中药复方制剂及其制备方法 | |
CN103272150A (zh) | 一种治疗甲状腺腺瘤的中药制剂 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN105079494A (zh) | 一种降血糖的铁皮石斛胶囊及其制备方法 | |
CN104147536A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
CN102698185B (zh) | 一种治疗高血脂症的藏药及其制备方法 | |
CN103751547B (zh) | 一种降血脂的中药组合物及其制备方法 | |
CN104225200A (zh) | 一种治疗饮凌心肺型心源性哮喘的中药及制备方法 | |
CN104606511B (zh) | 一种预防微创治疗腰椎间盘突出症术后反跳现象的中药 | |
CN100509041C (zh) | 清胃排毒丸 | |
CN103877384B (zh) | 一种治疗直肠癌的中药制剂及制备方法 | |
CN106581585A (zh) | 一种治疗胃溃疡的药物组合物 | |
CN103272147B (zh) | 一种治疗妊娠呕吐的中药制剂 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN103877390A (zh) | 一种治疗风湿热的中药制剂及制备方法 | |
CN103893327B (zh) | 一种治疗高脂血症的中药制剂及制备方法 | |
CN103006999B (zh) | 一种用于肾结石预防、治疗与护理的丸剂 | |
CN106728828A (zh) | 一种治疗冠心病的中药制剂及其制备工艺 | |
CN107569576B (zh) | 一种中药养肝护肝复方制剂及其制备方法和应用 | |
CN105288095A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN105194241A (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN106177480A (zh) | 一种包含青钱柳叶和石斛的降血糖保健组合物 | |
CN104225009A (zh) | 一种治疗腹泻的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiumei Pengcuo Inventor before: Song Yongxin |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161028 Address after: 810000 Xining biological science and Technology Industrial Park, No. three, No. 18, Qinghai Patentee after: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Address before: 810008 Qinghai province Xining City West District Xishan Lane 20 building No. 1 room 341 Patentee before: Song Yongxin |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Tibetan medicine for treating hyperlipidemia and preparation method thereof Effective date of registration: 20200525 Granted publication date: 20130619 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2020630000001 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210517 Granted publication date: 20130619 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2020630000001 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Tibetan medicine for treating hyperlipidemia and its preparation method Effective date of registration: 20210602 Granted publication date: 20130619 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230608 Granted publication date: 20130619 Pledgee: Qinghai Chuangqi Finance Leasing Co.,Ltd. Pledgor: Jiumei Pengcuo|Qinghai Jiumei Zang Drug Drug Co.,Ltd. Registration number: Y2021630000003 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |